He most recently served as a general partner at Mubadala Capital, building the firm's healthcare platform in the. --,,. com. Rami N. hannoush. ’s Post Rami Hannoush, Ph. Recent News and Activity. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. ’s Post Rami Hannoush, Ph. D. Taipale, P. Drug Discov. Electronic address: hannoush. Developing tool ligands that target individual LRP6 domains could help elucidate the mechanism of. Genentech Inc. We are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small. There are 3 professionals named "Rami Hannoush", who use LinkedIn to exchange information, ideas, and opportunities. ’s Post Rami Hannoush, Ph. D. Citizen and Immigration Services 2019 Outstanding Americans by. ’s Post Rami Hannoush, Ph. Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami. … | 79 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 1016/j. There are 3 professionals named "Rami Hannoush", who use LinkedIn to exchange information, ideas, and opportunities. Auron expands its leadership team with the appointments of David Millan, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6mo Edited Report this post It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. My group takes a genetic approach to studying signaling pathways relevant to human disease. D. Drug Discovery & Development Oncology Wnt and Stem Cells Peptide Therapeutics. Benjamin Moore, and Dr. The Section of Hematology/Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department. The site facilitates research and collaboration in academic endeavors. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Auron expands its leadership team with the appointments of David Millan, Ph. Additional Details: 1000 Ask Question Find a Lawyer. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Supplementary Figure 2 S6 . Rami Hannoush, Ph. Inventors: Stefan Dengl, Rami Hannoush, Simon Theodor Hansen, Peter Michael Huelsmann, Robert Franklin Kelley, Hubert Kettenberger, Shrenik Chetan Mehta, Devin Brent Tesar HYALURONIC ACID BINDING DERIVATIVES OF VERSICAN (VG1) FOR LONG ACTING DELIVERY OF THERAPEUTICSRead all stories published by MubadalaVentures in 2022. D. Proud to partner with a great team to systematically explore the untapped therapeutic potential of…“We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. He also recently joined Versant Ventures (as a venture partner) where he works on biotech company creation and life science investments. ’s Post Rami Hannoush, Ph. Connect Lana Janes, Ph. The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a critical role in their self-renewal. ’s Post Rami Hannoush, Ph. Rami Hannoush Manage my profile. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. , San Francisco, California, USA. D. The small size of the chemical tag is meant to minimize interference with fatty acyltransferase substrate recognition and catalytic efficiency (Hannoush, 2015, Hannoush and Arenas-Ramirez, 2009). Rami Hannoush, PhD. D. D. Rami Hannoush, Ph. Biomarker interview with Rami Hannoush, Ph. Rami Hannoush, Ph. D. Baran . Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human. Epub 2021 Dec 10. 1618293114 Abstract Frizzled (FZD) receptors mediate Wnt signaling in diverse processes ranging from bone growth to stem cell activity. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. D. 1038/nprot. D. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. Eric Shiozaki: Casdin Capital — BrightEdge Fund — Arkin Bio Ventures — Apollo Health Ventures . Scroll Top. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y Report this post Report Report. D. D. Recommended articles. The advent of click chemistry has propelled the field of protein palmitoylation forward by providing specific,. PMID: 24292069 DOI: 10. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 5W96, 5WBS. 2015. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular [email protected]. D. Dr. com. We cover his grad school/post-doc training in chemical biology, 15+ years as a group leader Genentech and. Scheme 2 S3 . Hannoush and Phil S. Welcome, Rami Hannoush, Ph. I am a Scientist in the Physiological Chemistry Department of Genentech's research organization. Its proprietary EpiTAC platform is a. Xinxin Gao 1 , Rami N Hannoush 1 Affiliation 1 Department of Early Discovery Biochemistry, Genentech, Inc. Speakers – APS 2022. 5 From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental. D. … | 77 comments on LinkedInRami Hannoush, Ph. Based on the protocol by Xinxin Gao and Rami N. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. com. D. Xinxin Gao, Xinxin Gao. He focuses on early-stage biotechnology investments, and also leads the firm’s efforts in life sciences company creation. . Rami Hannoush Ph. Rami Hannoush 7mo Report this post 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs and protect. D. ’s Post Rami Hannoush, Ph. D. The authors would like to acknowledge Dr. Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. D. “Jim and I have known each other for the past 15 years through Genentech. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Drug Discovery & Development Oncology Wnt and Stem. CSB 243: Biotechnology and Development of Therapeutics (Autumn)9 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. Marianne Mertens, [email protected]. She is taking over from co-founder Rami Hannoush, who will step into an advisory role. D. Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. Rami Hannoush, Ph. D. ’s Post Rami Hannoush, Ph. Fairbrother, ,* and Christian N. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…We would like to show you a description here but the site won’t allow us. View the profiles of professionals named "Rami Hannoush" on LinkedIn. Rami N. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. As a child growing up in a war-torn Lebanon, books provided both emotional and physical safety: “We used to sit down and read in the hallway outside of our apartment, since this was the safest place during times of bombing” (Q#1). Recommended articles. Dynasore inhibits cell proliferation of OS in vitro. EpiBiologics, Inc. D. degree at McGill University. ’s Post Rami Hannoush, Ph. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. D. The Wnt Signaling GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. rami@gene. Lee-Karlon left another Bay Area biotech company, Altos Labs, in June, according to her LinkedIn. It has been an incredible journey building this company. D. Rami N. There is no recent news or activity for this profile. We cover Rami's new role at Versant, the founding story of. D. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 10mo EditedUSA. D. Great chat with Ron Leuty from San Francisco Business Times to share our story on building EpiBiologics #companybuilding #degradation | 28 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. … | 79 comments on LinkedInRami Hannoush, Ph. Exploiting these “natural” garbage routes to destroy pathogenic proteins is a well-accepted therapeutic strategy—especially for disordered targets, or those hidden within lipid membranes:. , Partner at Mubadala Capital, and Dr. Expand search. Lawyers - Get Listed Now! Get a free. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. About this. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5'-phosphodiester linkages and play a prominent role in protein biosynthesis. When expanded it provides a list of search options that will switch the search inputs to match the. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular proteins. D. D. Gemma met Rami in 2011 when she was just starting out on the reality show The Only Way Is Essex. Synthetic therapeutic peptides: science and market. Hannoush's 87 research works with 3,279 citations and 10,017 reads, including: Synthetic Multivalent Disulfide-Constrained Peptide Agonists Potentiate Wnt1/β-Catenin. Jumi Shin, University of Toronto. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Connect Hamed Alemohammad Greater Boston. Rami Hannoush, Ph. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. g. D. Back. Healthcare VC | Life sciences company creation. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact EpiBiologics? Rami Hannoush, Ph. D. ” Prior to EpiBiologics, Dr. PMID: 30530496 PMCID: PMC6333880 Rami Hannoush, interim-CEO, said, “Since launching the company, the team at EpiBiologics has been able to further validate and industrialize the EpiTAC platform, creating a fit-for-purpose atlas of degraders. Publicación de Rami Hannoush, Ph. Supplementary Figures 1–7, Supplementary Tables 1–3 and Supplementary Methods. EpiBiologics is building a next-generation antibody-based protein degradation platform for membrane and extracellular drug targets. Rami Hannoush, Ph. منشور Rami Hannoush, Ph. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 1y. rami@gene. Mubadala Capital Ventures General Partner Sep 2021. Human OS cell lines (MNNG/HOS, MG-63, and U2-OS) were treated with increasing concentrations of dynasore or cisplatin, and then the cell. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7mo Report this post What are some of the factors that contribute to aging? And could we identify the specific mechanisms by which these factors impair tissue regeneration?Rami Hannoush, Ph. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Many proteins have been found to be regulated through S-palmitoylation, a highly conserved process occurring in all eukaryotic organisms that involves the attachment of 16-carbon fatty acids onto cysteine residues via a reversible thioester linkage (Chamberlain and Shipston, 2015, Hannoush, 2015). Manage my profile. Baran . D. D. Rami Hannoush, Ph. Expand search. The small size of the chemical tag is meant to minimize interference with fatty acyltransferase substrate recognition and catalytic efficiency (Hannoush, 2015, Hannoush and Arenas. Auron Therapeutics, a Newton, Mass. , Department of Protein Engineering, 1 DNA Way, South San Francisco, CA 94080, USA, hannoush. D. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6d EditedRami Hannoush, Ph. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Connect Alison Symington Strategic expertise in bringing innovation in the life sciences. Targeting the destruction of proteins, Peninsula biotech EpiBiologics raises $50M. One of many physiological findings about lipid–protein interaction is that lipid modifications regulate some proteins generated by cancer genes, says Rami Hannoush, a chemical biologist at the. Xinxin Gao and Rami Hannoush designed and analyzed experiments and wrote the paper. Wnt ligands are critical for tissue homeostasis and form a complex with LRP6 and frizzled coreceptors to initiate Wnt/β-catenin signaling. This button displays the currently selected search type. Rami Hannoush, Ph. Hannoush is a general partner at Mubadala Capital, the financial investment arm of the Sovereign Wealth Fund Mubadala. Mar 22, 2023. has lived in San Mateo, CA Watertown, MA 1200 Massachusetts Ave, Cambridge, MA 02138 Foster City, CA. Inventors: Eric Bourhis, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark. D. "To our knowledge, no one has identified ligands that bind to the zymogen," said senior author Rami Hannoush, Genentech, South San Francisco, California. D. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Edited Report this post Report Report. Hannoush joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. Its proprietary EpiTAC platform is a. ’s Post Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 3mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. Possible relatives for Rana Bibi include Amaly Bibi, Rami Bibi and Bibi Samer. D. , USA) "Challenges and Emerging Approaches in Peptide Drug Discovery" 9:25 am - 9:40 am: Discussion. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. Hannoush* and Natalia Arenas-Ramirez . EpiBiologics Executive Team & Key Decision Makers. Rami Hannoush, Ph. 4 the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080, and hannoush. It is tightly controlled by a set of enzymes which catalyze the covalent attachment of fatty. Additional Details: 1000 Ask Question Find a Lawyer. Related to: Rana Hannoush, 42. Mubadala Capital Ventures General Partner Sep 2021. San Mateo, CA. … | 79 comments on LinkedInAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Publicação de Rami Hannoush, Ph. , Partner at Mubadala Capital, and Dr. D. Phone and address: 35 28Th Ave #300, San Mateo, CA 94403. Courtesy of EpiBiologics. Rami Hannoush, Ph. D. com. Founded in 2022 and led by CEO Dr. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. ’s Post Rami Hannoush, Ph. Ethics declarations. D. Funds will also. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact. ”Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Conference Description. Prior to his current role, he was a. D. Congratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. Rami N. Healthcare VC | Life sciences company creation 2yThe 2020 Chemistry and Biology of Peptides Gordon Research Conference will showcase the most recent, cutting edge research in advancing peptides as tools, materials, and therapeutics. Rami Hannoush. 1038/s41589-018-0035-2 Abstract Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing. Rami Hannoush, Ph. Determination of binding interactions between lipid-modified Wnt. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo EditedRami Hannoush, Ph. Background. Name & Title Social Contact Info; Craig Lichtenstein. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. We cover Rami's new role at Versant, the founding story of. rami@gene. Xinxin Gao 1 , Rami N Hannoush 1 Affiliation 1 Department of Early Discovery Biochemistry, Genentech, Inc. On average, Rami Hannoush works for one company for 2 years 7 months. D. D. Rami Hannoush, Ph. Rami N. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 3h Report this post. D. Journal of the American Chemical Society 2009, 131 (26) , 9172-9173. doi: 10. D. -based biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular. Xinxin Gao 1and Rami N. D. ’s Post Rami Hannoush, Ph. When expanded it provides a list of search options that will switch the search inputs to match the. D. Rami Hannoush serves as Venture Partner at Versant Ventures. D. . Seminar Title: Challenging Targets and Emerging Approaches for Cellular Imaging in the Wnt Pathway, powered by Localist Event Calendar SoftwareRami Hannoush, Ph. D. Founded in 2022 and led by CEO Dr. ’s Post Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. D. D. This button displays the currently selected search type. … | 79 comments on LinkedInRami Hannoush, Ph. D. Back Submit. Healthcare VC | Life sciences company creation 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. 19th Ave New York, NY 95822, USA. D. J Pharm Sci 2022 07 10;111(7):1896-1910. D. Rami Hannoush, Ph. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts. Synthetic protein lipidation. "To our knowledge, no one has identified ligands that bind to the zymogen," said senior author Rami Hannoush, Genentech, South San Francisco, California. D. Rami Hannoush is a venture partner operating across San Diego and the San Francisco Bay Area. They found a peptide that converts the caspase to its inactive state—the zymogen—and traps it there, a bit like a wheel clamp. com. D. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. Antibody Engineering & Therapeutics is the largest forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation bindersRami Hannoush, Ph. Rami Hannoush, Ph. Apply now and find other jobs on WIZBIIRami Hannoush, Ph. D. D. EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with the addition of $23 million from new investors Digitalis Ventures, Taiho Ventures, and existing investor Codon Capital. Baig et al. Rami N. View the profiles of professionals named "Rami D" on LinkedIn. D. Yen, founder and CEO. THE AURON TEAM A CULTURE OF INNOVATION. , as Chief Data Officer,. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha. hannoush. Much less common are ribonucleic acids based on 2',5'-phosphodiester linkages (2',5'-RNA). D. Contents: Chemical Synthesis S2 . Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 4mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. He brings a unique blend of investment experience and deep drug discovery expertise to our. Profile Previews—Driven by the PitchBook Platform. Rami Hannoush, Ph. Rami Hannoush is the co-founder, interim CEO and president of EpiBiologics. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. ACS Chemical Biology editors highlight articles from Volume 4, Issue 7, and speak with authors Rami Hannoush and Domagoj Vucic. D. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush, Ph. rami@gene. Rami Hannoush, Ph. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 6mo Edited Report this post Great chat with. Rami Hannoush’s Post. Hannoush (hannoush. Reprints and Permissions. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu Ask a Lawyer. On average, Rami Hannoush works for one company for 2 years 7 months. Edit Recent News and Activity Section. Over the weekend, I received the Outstanding Recent Alumnus Award alongside some incredibly accomplished individuals. Biomarker interview with Rami Hannoush, Ph. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5. ’s Post Rami Hannoush, Ph. Specific lab interests include Wnt signaling, protein. 11mo Report this comment Report Report. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu Ask a Lawyer. 2014. Congrats Cameron! Like Reply 1 Reaction. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6mo Edited Report this post. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. Hannoush is a general partner at Mubadala Capital, the financial investment arm of the Sovereign Wealth Fund Mubadala. By Ron Leuty – Senior Reporter, San Francisco Business Times. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. D. ’s Post Rami Hannoush, Ph. EpiBiologics - a biotechnology company advancing a next-generation antibody-based protein degradation platform and pipeline for membrane and extracellular drug targets - recently announced the company brought the total series A round to $73 million with the addition of $23 million from new investors Digitalis Ventures, Taiho. Palmitate can either be added to. Born on September 20th, 1976 (47 years old)Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Rami Hannoush 5d · Edited Report this post Report Report. Marianne Mertens, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Report this post Report Report. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. Search for a company, investor, advisor, limited partner, fund or professional to preview their profile. Around five percent of coding genes are involved in lipid metabolism and lipid2 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. When expanded it provides a list of search options that will switch the search inputs to match the. Mubadala Capital Ventures General Partner Sep 2021.